secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001493152-24-006163
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals effectuates 1-for-30 reverse stock split to maintain Nasdaq listing
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-30 ratio effective Feb 14, 2024 at 4:05 p.m. EST.
- Outstanding shares reduced from ~62.7M to ~2.09M; authorized shares reduced from 500M to 16.67M.
- Common stock begins trading on split-adjusted basis Feb 15 under same ticker MYMD; new CUSIP 62856X201.
- Fractional shares rounded up to nearest whole share; proportional adjustments to warrants, preferred stock, and equity awards.
- Company states split is intended to maintain compliance with Nasdaq listing requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224006163/0001493152-24-006163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224006163/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-006163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer